| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-05 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.001 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.003 |